(Q38055295)

27 August 2017

title

Empowering people with diabetes: improving perceptions and outcomes with technical advances in insulin pens (English)

1 reference

27 August 2017

David Oyer

1

1 reference

27 August 2017

Marcus Niemeyer

series ordinal

2

1 reference

27 August 2017

Alan Moses

series ordinal

3

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

27 August 2017

published in

Postgraduate Medicine

1 reference

27 August 2017

volume

124

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

110-120

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Psychological insulin resistance: patient beliefs and implications for diabetes management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Correlates of insulin injection omission

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

FlexPen: addressing issues of confidence and convenience in insulin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Effect of patient-selected intensive insulin therapy on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Preference for insulin delivery systems among current insulin users and nonusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Preference and resource utilization in elderly patients: InnoLet versus vial/syringe.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Insulin pen-the "iPod" for insulin delivery (why pen wins over syringe)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Dose accuracy and injection force dynamics of a novel disposable insulin pen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Comparison of the dose accuracy of prefilled insulin pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Differences in the dose accuracy of insulin pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Dosing accuracy of commonly used disposable insulin pens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Study on the dosing accuracy of commonly used disposable insulin pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1 U), medium- (40 U), and high- (80 U) dose settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Health economics and compliance of vials/syringes versus pen devices: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Ease of use and patient preference injection simulation study comparing two prefilled insulin pens

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Needle with a novel attachment versus conventional screw-thread needles: a preference and ease-of-use test among children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Factors affecting use of insulin pens by patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2012.09.2587

21 January 2018

Identifiers

DOI

10.3810/PGM.2012.09.2587

1 reference

27 August 2017

1 reference